Biotech Stock News (CMRX) (PTCT) (SRPT) (BMRN) (PPHM)

Chimerix (NASDAQ:CMRX)  On Monday February 22, 2016 shares of Chimerix tumbled by 40% as the company announced that two phase 3 trials had to be stopped because of lack of efficacy. The phase 3 trial, known as the SUPPRESS trial, recruited a total of 452 patients. The patients that were recruited in the trial were … Read more

BioMarin (BMRN) Pharmaceutical Stock Climbs On Positive Study Data

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) BioMarin Pharmaceutical stock is up today after releasing positive results with regard to the Phase 2 proof-of-concept and dose funding study of BMN 111, also known as vosoritide. Today, we’ll take a look at the results to see what investors are so excited about, talk about what we’ve seen in … Read more

Biotech Stock News (SRPT) (BMRN) (PBMD) (ISR)

Sarepta Therapeutics (NASDAQ:SRPT) After the closing bell on May 19, 2015 shares of Sarepta Therapeutics were up as much as 38% in after-hours trading after the company reported that the FDA will allow the company to file a New Drug Application — NDA — for Eteplirsen. This drug Eteplirsen helps patients with Duchenne Muscular Dystrophy … Read more